Sanjay R Chemburkar

This inventor holds 27 USPTO granted patents and 11 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Melinta Therapeutics, Inc.. Active years: 1992-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjay R Chemburkar. Retrieved from https://idiyas.com/inventor/sanjay-r-chemburkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 11)

% Patents Active = 66.7

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 76(Granted Patents)

Location History:

North Chicago, IL (US) (2017 - 2020)
Gurnee, IL (US) (1992 - 2023)

Company Filing History:

15 out of 4,188

Abbott Laboratories Corporation

Melinta Therapeutics, Inc.

patents

4. 1 out of 26

The Medicines Company

patents

where one patent can have more than one assignee

Years Active: 1992-2023

Loading Chart...

Areas of Expertise:

Elagolix

Oritavancin

Enzymatic Processes

Polymorphs

Crystalline Pharmaceuticals

Retroviral Protease Inhibitors

Amino Acids

Tetrazole Derivatives

Spirocyclopropyl

Synthesis

Pharmaceutical Compositions

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542239 - Elagolix sodium compositions and processes (2023-01-03),

2. 10864249 - High purity oritavancin and method of producing same (2020-12-15),

3. 10689675 - Enzymatic processes for the preparation of (±)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (±)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid (2020-06-23),

4. 10465216 - Process for the preparation of (S)-2-amino-non-8-enoic acid (2019-11-05),

5. 10328118 - High purity oritavancin and method of producing same (2019-06-25),

6. 10316338 - Enzymatic process for the preparation of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acid (2019-06-11),

7. 10113152 - Variant polypeptides capable of aminating aliphatic alpha keto acids (2018-10-30),

8. 10059969 - Process for the preparation of (S)-2-amino-non-8-enoic acid (2018-08-28),

9. 9649352 - High purity oritavancin and method of producing same (2017-05-16),

10. 9255092 - Polymorph of a pharmaceutical (2016-02-09),

11. 8796451 - Crystalline pharmaceutical (2014-08-05),

12. 8674112 - Polymorph of a pharmaceutical (2014-03-18),

13. 8288565 - Process for the synthesis of (2S,3AR,7AS)-octahydro-1H-indole carboxylic acid as an intermediate for trandolapril (2012-10-16),

14. 8193367 - Polymorph of a pharmaceutical (2012-06-05),

15. 8129521 - One pot synthesis of tetrazole derivatives of rapamycin (2012-03-06),

Title: The Innovation Journey of Inventor Sanjay R Chemburkar

Introduction: Sanjay R Chemburkar, a prolific inventor based in Gurnee, IL (US), has made significant contributions to the field of pharmaceuticals with a total of 27 patents to his name.

Latest Patents:

1. Elagolix sodium compositions and processes - Chemburkar's innovative work revolves around compositions of elagolix sodium, along with the processes and intermediates involved in their preparation.

2. High purity oritavancin and method of producing same - Chemburkar's patents also include drug substance preparations of oritavancin with high purity, pharmaceutical compositions containing such preparations, and drug products with these compositions.

Career Highlights: Throughout his career, Sanjay R Chemburkar has worked with esteemed companies such as Abbott Laboratories Corporation and AbbVie Inc., where he honed his skills and expertise in the pharmaceutical industry.

Collaborations: Chemburkar has collaborated with notable individuals in his field, including coworkers Ketan M Patel and Harry O Spiwek, fostering a culture of innovation and teamwork in his professional endeavors.

Conclusion: Sanjay R Chemburkar's relentless pursuit of innovation in pharmaceuticals has not only led to numerous patents but has also established him as a respected figure in the industry. His groundbreaking work continues to shape the landscape of pharmaceutical research and development, inspiring future generations of inventors.

Profile summary based on public USPTO records.